Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.

MLA

Ercalik, Nimet Yesim, et al. “Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.” Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics, vol. 32, no. 4, May 2016, pp. 225–29. EBSCOhost, https://doi.org/10.1089/jop.2015.0092.

APA

Ercalik, N. Y., Yenerel, N. M., Imamoglu, S., Kumral, E. T., & Vural, E. T. (2016). Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment. Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics, 32(4), 225–229. https://doi.org/10.1089/jop.2015.0092

Chicago

Ercalik, Nimet Yesim, Nursal Melda Yenerel, Serhat Imamoglu, Esra Türkseven Kumral, and Ece Turan Vural. 2016. “Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.” Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics 32 (4): 225–29. doi:10.1089/jop.2015.0092.